open access
Suppression of the inflammation and fibrosis in Asherman syndrome rat model by mesenchymal stem cells: histological and immunohistochemical studies
- Department of Medical Histology and Cell Biology, Faculty of Medicine, Cairo University, Cairo, Egypt
open access
Abstract
Introduction. Asherman syndrome (AS) is a symptomatic intrauterine adhesion caused by endometrial basal layer fibrosis as a result of either uterine cavity surgery or infection leading to many complications. There is a concern to repair the injured tissues by using bone marrow mesenchymal stem cells (BM-MSCs). We aimed in this study to develop an animal model of AS and evaluate the anti-inflammatory and anti-fibrotic effects of BM-MSCs in this model through histological, immunohistochemical, and morphometric studies. Material and methods. Forty-two adult female adult albino rats were divided into (i) donor group composed of 2 rats used for isolation and propagation of BM-MSCs, and (ii) experimental groups: 40 rats equally divided into 4 groups: GpI (control), GpII (AS model), GpIII (BM-MSCs-treated AS rats), GpIV (untreated AS rats). Histological staining and immunohistochemical (IHC) detection of proliferating cell nuclear antigen (PCNA), vascular endothelial growth factor (VEGF), and nuclear factor-kappa beta (NF-kB) were performed. The results were evaluated by morphometric and statistical analysis. Results. Significant endometrial thinning, fibrosis, and degeneration of the endometrial epithelium with a significant decrease in PCNA and VEGF immunoexpression and a significant increase in NF-kB immunoexpression were detected in GpII and GpIV groups. These changes were substantially reversed in BM-MSCs-treated animals. Conclusions: BM-MSCs treatment resulted in substantial improvement of intrauterine adhesion in the rat model of Asherman syndrome.
Abstract
Introduction. Asherman syndrome (AS) is a symptomatic intrauterine adhesion caused by endometrial basal layer fibrosis as a result of either uterine cavity surgery or infection leading to many complications. There is a concern to repair the injured tissues by using bone marrow mesenchymal stem cells (BM-MSCs). We aimed in this study to develop an animal model of AS and evaluate the anti-inflammatory and anti-fibrotic effects of BM-MSCs in this model through histological, immunohistochemical, and morphometric studies. Material and methods. Forty-two adult female adult albino rats were divided into (i) donor group composed of 2 rats used for isolation and propagation of BM-MSCs, and (ii) experimental groups: 40 rats equally divided into 4 groups: GpI (control), GpII (AS model), GpIII (BM-MSCs-treated AS rats), GpIV (untreated AS rats). Histological staining and immunohistochemical (IHC) detection of proliferating cell nuclear antigen (PCNA), vascular endothelial growth factor (VEGF), and nuclear factor-kappa beta (NF-kB) were performed. The results were evaluated by morphometric and statistical analysis. Results. Significant endometrial thinning, fibrosis, and degeneration of the endometrial epithelium with a significant decrease in PCNA and VEGF immunoexpression and a significant increase in NF-kB immunoexpression were detected in GpII and GpIV groups. These changes were substantially reversed in BM-MSCs-treated animals. Conclusions: BM-MSCs treatment resulted in substantial improvement of intrauterine adhesion in the rat model of Asherman syndrome.
Keywords
BM-MSCs; intrauterine adhesions; NF-kB; PCNA; VEGF; IHC
Title
Suppression of the inflammation and fibrosis in Asherman syndrome rat model by mesenchymal stem cells: histological and immunohistochemical studies
Journal
Folia Histochemica et Cytobiologica
Issue
Article type
Original paper
Pages
208-218
Published online
2020-09-30
Page views
5558
Article views/downloads
1691
DOI
Pubmed
Bibliographic record
Folia Histochem Cytobiol 2020;58(3):208-218.
Keywords
BM-MSCs
intrauterine adhesions
NF-kB
PCNA
VEGF
IHC
Authors
Naglaa Mohamed Salama
Somaia Saad Zaghlol
Hala Hassan Mohamed
Samaa Samir Kamar
- Dreisler E, Kjer JJ. Asherman's syndrome: current perspectives on diagnosis and management. Int J Womens Health. 2019; 11: 191–198.
- Wang X, Ma N, Sun Q, et al. Elevated NF-κB signaling in Asherman syndrome patients and animal models. Oncotarget. 2017; 8(9): 15399–15406.
- March CM. Management of Asherman's syndrome. Reprod Biomed Online. 2011; 23(1): 63–76.
- Wang J, Ju B, Pan C, et al. Application of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions in Rats. Cell Physiol Biochem. 2016; 39(4): 1553–1560.
- Conforti A, Alviggi C, Mollo A, et al. The management of Asherman syndrome: a review of literature. Reprod Biol Endocrinol. 2013; 11: 118.
- Sabry D, Mostafa A, Marzouk S, et al. Neupogen and mesenchymal stem cells are the novel therapeutic agents in regeneration of induced endometrial fibrosis in experimental rats. Biosci Rep. 2017; 37(5).
- Tang L, Chen Yu, Pei F, et al. Lithium Chloride Modulates Adipogenesis and Osteogenesis of Human Bone Marrow-Derived Mesenchymal Stem Cells. Cell Physiol Biochem. 2015; 37(1): 143–152.
- Golpanian S, Wolf A, Hatzistergos KE, et al. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev. 2016; 96(3): 1127–1168.
- Santamaria X, Cabanillas S, Cervelló I, et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016; 31(5): 1087–1096.
- Cocuzza MA, Cocuzza M, Maciel GAR, et al. Development of an animal model for endometrial ablation using trichloroacetic acid. Fertil Steril. 2011; 95(7): 2418–2421.
- Kilic S, Yuksel B, Pinarli F, et al. Effect of stem cell application on Asherman syndrome, an experimental rat model. J Assist Reprod Genet. 2014; 31(8): 975–982.
- Jing Z, Qiong Z, Yonggang W, et al. Rat bone marrow mesenchymal stem cells improve regeneration of thin endometrium in rat. Fertil Steril. 2014; 101(2): 587–594.
- Alhadlaq A, Mao JJ. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 2004; 13(4): 436–448.
- Mohi El-Din MM, Rashed LA, Mahmoud Haridy MA, et al. Impact of bone marrow-derived mesenchymal stem cells on remodeling the lung injury induced by lipopolysaccharides in mice. Future Sci OA. 2017; 3(1): FSO162.
- MT AA, MA, W. Mesenchymal Stem Cells Therapy in Acute Renal Failure: Possible Role of Hepatocyte Growth Factor. J Stem Cell Res Ther. 2011; 01(03).
- Yener T, Turkkani Tunc A, Aslan H, et al. Determination of oestrous cycle of the rats by direct examination: how reliable? Anat Histol Embryol. 2007; 36(1): 75–77.
- Bancroft JD, Gamble M. The hematoxylin and eosin. In: Theory and Practice of Histological Techniques, 6th ed. London: Churchill Livingstone. ; 2008: 121–134.
- Bancroft JD, Gamble M. 2008. Connective tissue and stain. In: Theory and Practice of Histological Techniques, 6th ed. London: Churchill Livingstone. ; 2008: 147–150.
- Smikle C, Khetarpal S. Asherman Syndrome. Stat Pearls [Internet], Treasure Island (FL), StatPearls Publishing. ; 2020.
- Guo EJ, Chung JP, Poon LC, et al. Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review. Best Pract Res Clin Obstet Gynaecol. 2019; 59: 98–114.
- Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol. 2008; 20(3): 221–228.
- Eftekhar M, Tabibnejad N, Tabatabaie A. The thin endometrium in assisted reproductive technology: An ongoing challenge. Middle East Fertility Society Journal. 2018; 23(1): 1–7.
- Luckett-Chastain LR, Gallucci RM. Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice. Br J Dermatol. 2009; 161(2): 237–248.
- Ramalho BD, Almeida FM, Sales CM, et al. Injection of bone marrow mesenchymal stem cells by intravenous or intraperitoneal routes is a viable alternative to spinal cord injury treatment in mice. Neural Regen Res. 2018; 13(6): 1046–1053.
- Zickri MB, Fadl SG, Metwally HG. Comparative Study between Intravenous and Intraperitoneal Stem Cell Therapy in Amiodarone Induced Lung Injury in Rat. Int J Stem Cells. 2014; 7(1): 1–11.
- Fu Y, Karbaat L, Wu L, et al. Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration. Tissue Eng Part B Rev. 2017; 23(6): 515–528.
- Horton JA, Hudak KE, Chung EJ, et al. Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation. Stem Cells. 2013; 31(10): 2231–2241.
- Ebrahim N, Mostafa O, El Dosoky RE, et al. Human mesenchymal stem cell-derived extracellular vesicles/estrogen combined therapy safely ameliorates experimentally induced intrauterine adhesions in a female rat model. Stem Cell Res Ther. 2018; 9(1): 175.
- Toh WS, Lai RC, Zhang B, et al. MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans. 2018; 46(4): 843–853.
- Zhang S, Teo KY, Chuah SJ, et al. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. Biomaterials. 2019; 200: 35–47.
- Omar A, Aboulkhair A. Do microvesicles derived from adipose mesenchymal stem cells have a therapeutic potential on Escherichia coli lipopolysaccharides-induced sepsis in Zona fasciculata of adult male albino rats? A histological study. EJH. 2018; 41(2): 204–219.
- Kang MS, Ryu E, Lee SW, et al. Regulation of PCNA cycling on replicating DNA by RFC and RFC-like complexes. Nat Commun. 2019; 10(1): 2420.
- Li B, Zhang Q, Sun J, et al. Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. Stem Cell Res Ther. 2019; 10(1): 257.
- Shawky LM, El Bana EA, Morsi AA. Stem cells and metformin synergistically promote healing in experimentally induced cutaneous wound injury in diabetic rats. Folia Histochem Cytobiol. 2019; 57(3): 127–138.
- Mohsen RO, Halawa AM, Hassan R. Role of bone marrow-derived stem cells versus insulin on filiform and fungiform papillae of diabetic albino rats (light, fluorescent and scanning electron microscopic study). Acta Histochem. 2019; 121(7): 812–822.
- Fu X, Liu Ge, Halim A, et al. Mesenchymal Stem Cell Migration and Tissue Repair. Cells. 2019; 8(8).
- Miwa I, Tamura H, Takasaki A, et al. Pathophysiologic features of "thin" endometrium. Fertil Steril. 2009; 91(4): 998–1004.
- Santamaria X, Isaacson K, Simón C. Asherman's Syndrome: it may not be all our fault. Hum Reprod. 2018; 33(8): 1374–1380.
- Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009; 1(6): a001651.
- Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017; 2.
- Xue X, Chen Q, Zhao G, et al. The Overexpression of TGF-β and CCN2 in Intrauterine Adhesions Involves the NF-κB Signaling Pathway. PLoS One. 2015; 10(12): e0146159.
- Su VYF, Lin CS, Hung SC, et al. Mesenchymal Stem Cell-Conditioned Medium Induces Neutrophil Apoptosis Associated with Inhibition of the NF-κB Pathway in Endotoxin-Induced Acute Lung Injury. Int J Mol Sci. 2019; 20(9).
- Kharaziha P, Hellström PM, Noorinayer B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009; 21(10): 1199–1205.
- Caplan H, Olson SD, Kumar A, et al. Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application. Front Immunol. 2019; 10: 1645.